期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 212, 期 12, 页码 2003-2013出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20150892
关键词
-
资金
- Fund for Scientific Research, Flanders
- KU Leuven
- Flemisch Government
- Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office
- Instituto de Salud Carlos III [PI10/00018]
- CIB ERNED
- Medical Research Council
- Alzheimer's Society
- Alzheimer's Research UK
- National Institute for Health Research (NIHR) Queen Square Biomedical Unit in Dementia
- Leonard Wolfson Experimental Neurology Centre
- Hamburg State Ministry of Science and Research
- Landesforschungsforderung Molekulare mechanismen der netzwerkmodifizierung
- Brain Exit Fellowship
- Alzheimer's Research UK fellowship
- Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease
- IWT Agency for Innovation by Science and Technology
- Janssen Pharmaceutica
- MRC [G0900421] Funding Source: UKRI
- Medical Research Council [G0900421] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish
Presenilin (PSEN) pathogenic mutations cause familial Alzheimer's disease (AD [FAD]) in an autosomal-dominant manner. The extent to which the healthy and diseased alleles influence each other to cause neurodegeneration remains unclear. In this study, we assessed gamma-secretase activity in brain samples from 15 nondemented subjects, 22 FAD patients harboring nine different mutations in PSEN1, and 11 sporadic AD (SAD) patients. FAD and control brain samples had similar overall gamma-secretase activity levels, and therefore, loss of overall (endopeptidase) gamma-secretase function cannot be an essential part of the pathogenic mechanism. In contrast, impaired carboxypeptidase-like activity (gamma-secretase dysfunction) is a constant feature in all FAD brains. Significantly, we demonstrate that pharmacological activation of the carboxypeptidase-like gamma-secretase activity with gamma-secretase modulators alleviates the mutant PSEN pathogenic effects. Most SAD cases display normal endo-and carboxypeptidase-like gamma-secretase activities. However and interestingly, a few SAD patient samples display gamma-secretase dysfunction, suggesting that gamma-secretase may play a role in some SAD cases. In conclusion, our study highlights qualitative shifts in amyloid-beta (A beta) profiles as the common denominator in FAD and supports a model in which the healthy allele contributes with normal A beta products and the diseased allele generates longer aggregation-prone peptides that act as seeds inducing toxic amyloid conformations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据